Fundraising FoxNovapep
San Diego, US · 1 known investors
Find your way into Novapep
Sign up to see every warm intro you have to Novapep
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Novapep team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Novapep is an Australian-US biotech company developing G10, a polypeptide agonist that mimics activated protein C signaling to reduce inflammation. The company focuses on peptide-based therapeutics for inflammatory and infectious diseases.
Founders & leadership
JG
John GriffinCo-founder
LM
Laurent MosnierCo-founder
CJ
Chris JacksonCo-founder
JH
Jay HennockCEO & Executive Director
KP
Kent PryorExecutive Director
Board
RA
Rob AntulovChairman
Investors · 1
Frequently asked questions
- What does Novapep do?
- Novapep is an Australian-US biotech company developing G10, a polypeptide agonist that mimics activated protein C signaling to reduce inflammation. The company focuses on peptide-based therapeutics for inflammatory and infectious diseases.
- Who founded Novapep?
- Novapep was founded by John Griffin, Laurent Mosnier, Chris Jackson.
- Who are Novapep's investors?
- Novapep's investors include Sydney Angels.
- Where is Novapep headquartered?
- Novapep is headquartered in San Diego, US.